The Globe and Mail reports in its Friday, Nov. 17, edition that National Bank analyst Cameron Doerksen assumed coverage on Andlauer Healthcare Group with a "sector perform" recommendation and $46 share target. The Globe's David Leeder writes in the Eye On Equities column that analysts on average target the shares at $49.36. The Globe says Mr. Doerksen calls Andlauer Healthcare "a high quality, well-managed company with attractive long-term secular growth drivers." Andlauer specializes in logistics and delivery solutions for the health care sector. Mr. Doerksen says in a note: "We see more torque in some other stocks in our coverage universe. We forecast that Andlauer Healthcare will see a resumption of earnings growth in 2024 supported by underlying healthcare industry growth trends. The total return from the current share price to our $46 target is attractive at 17 per cent. However, if one believes the current freight recession (which started in early 2022) ends in 2024, earnings growth (and likely share price upside) for some other stocks in our transportation coverage universe could be more compelling than the potential upside for Andlauer shares over the next 12 months."